Allspring Global Investments’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $59.4M | Buy |
3,320,251
+271,305
| +9% | +$4.85M | 0.1% | 244 |
|
2025
Q1 | $59.2M | Buy |
3,048,946
+207,097
| +7% | +$4.02M | 0.1% | 250 |
|
2024
Q4 | $51M | Buy |
2,841,849
+2,613,482
| +1,144% | +$46.9M | 0.08% | 293 |
|
2024
Q3 | $4.57M | Buy |
228,367
+17,573
| +8% | +$351K | 0.01% | 967 |
|
2024
Q2 | $2.36M | Sell |
210,794
-41,808
| -17% | -$467K | ﹤0.01% | 1131 |
|
2024
Q1 | $1.67M | Buy |
252,602
+7,463
| +3% | +$49.3K | ﹤0.01% | 1241 |
|
2023
Q4 | $1.11M | Sell |
245,139
-34,332
| -12% | -$155K | ﹤0.01% | 1317 |
|
2023
Q3 | $1M | Buy |
279,471
+81,995
| +42% | +$294K | ﹤0.01% | 1359 |
|
2023
Q2 | $729K | Buy |
197,476
+79,320
| +67% | +$293K | ﹤0.01% | 1486 |
|
2023
Q1 | $391K | Buy |
118,156
+83,660
| +243% | +$277K | ﹤0.01% | 1636 |
|
2022
Q4 | $134K | Sell |
34,496
-669
| -2% | -$2.6K | ﹤0.01% | 1952 |
|
2022
Q3 | $85K | Buy |
+35,165
| New | +$85K | ﹤0.01% | 2138 |
|